Dragon Q Energy sends help to power up Malibu
In response to the Los Angeles Wildfires that have ravaged the county, such as the Palisades Fire which has left thousands of homes and businesses destroyed and many more without electricity and internet connectivity, Dragon Q Energy is stepping up to the challenge. The Santa Barbara-based company that specializes in battery technology deployed its PowerPole technology to Read More →
Teledyne finishes fiscal year strong with record Q4
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
A2 Bio closes $80M Series C capital raise
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Sonos CEO steps down following app debacle
Consequences of Sonos’ decision to overhaul and release a new version of its app — one that was riddled with bugs and missing key features — came to fruition on Jan. 13 after the company announced it would be looking for a new CEO to start the new year. Sonos, a maker of speakers, headphones Read More →
PBS Biotech secures $17 million in follow-on round
One year after the company raised $22 million in financing, Camarillo-based PBS Biotech secured another $17 million in follow-on growth capital from Avego Management and BroadOak Capital Partners. Announced Jan. 6, the investment will help accelerate PBS Biotech’s new product innovation, process development services, and quality system improvements, further advancing the cell therapy industry and helping their Read More →
A2 Bio closes $80 million Series C financing round
Agoura Hills-based A2 Biotherapeutics, a clinical-stage cell therapy company, on Jan. 9 announced the closing of its $80 million Series C financing round, supported by a syndicate of investors that includes The Column Group and Samsara BioCapital. A2 Bio is developing first-in-class logic-gated cell therapies to selectively target tumor cells and protect normal cells. Proceeds Read More →
805 Tech: Region’s investments in AI will continue paying off
Let’s get this out of the way now. If you got tired of hearing about artificial intelligence and how it is going to revolutionize our way of life, well, fair warning, that isn’t going to stop in 2025. In fact, that’s probably the majority of tech trends you’re going to hear about — and the Central Read More →
